These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4681407)

  • 1. [Effects of methyldigoxin administered orally and intravenously on the myocardial contraction in the normal man].
    Bellocci F; Carbonin PU; Zecchi P; Ruffa S; Loperfido F
    Boll Soc Ital Cardiol; 1972; 17(10):854-7. PubMed ID: 4681407
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of action of beta-methyldigoxin and digoxin utilizing systolic time intervals.
    Katdare AD; Namjoshi SA; Nair KG
    J Int Med Res; 1980; 8(1):50-5. PubMed ID: 7358204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic turnover of methyldigoxin-H 3 , administered orally and intravenously in normal man].
    Carbonin PU; Zecchi P; Bellocci F; Ruffa S; Loperfido F
    Boll Soc Ital Cardiol; 1971; 16(11):721-6. PubMed ID: 5147478
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative pharmacodynamics of betamethyl digoxin and digoxin in man.
    Das GP; Talmers RN; Weissler AM
    Clin Pharmacol Ther; 1977 Sep; 22(3):280-5. PubMed ID: 891096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of chronic digoxin administration on the systolic intervals of a healthy young person].
    Tomas-Verdera Cosmelli J; García del Pozo JM; López Morales J; Palou de Comasema A; Morey Molina A
    Rev Esp Cardiol; 1977; 30(1):53-7. PubMed ID: 854626
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative comparison of the magnitude and course of action of B-methyldigoxin and digoxin (a study based on systolic time intervals).
    Dalal S; Bhatia ML
    J Assoc Physicians India; 1978 May; 26(5):361-6. PubMed ID: 730715
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin pharmacokinetics, bioavailability, efficacy, and dosage regimens in the horse.
    Button C; Gross DR; Johnston JT; Yakatan GJ
    Am J Vet Res; 1980 Sep; 41(9):1388-95. PubMed ID: 7447132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of congestive heart failure with beta-methyldigoxin (lanitop)].
    Bart BIa; Biriukova MN; Savenkov PM; Rumiantseva IA
    Kardiologiia; 1977 Apr; 17(4):97-101. PubMed ID: 886729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Threshold of action of meproscillarin following intravenous administration].
    Belz GG; Aust PE
    Med Klin; 1980 Jul; 75(15):551-3. PubMed ID: 7001203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood digital in dysproteinemia after oral administration of methyldigoxin].
    Carbonin PU; Greco AV; Ruffa S; Cocchi A
    Boll Soc Ital Cardiol; 1973; 18(7):677-8. PubMed ID: 4807157
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.
    Hinderling PH; Garrett ER; Wester RD
    J Pharm Sci; 1977 Feb; 66(2):242-53. PubMed ID: 839422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspectives on intravenous administration of digoxin.
    Cooke DM
    J Intraven Nurs; 1992; 15(6):310-4. PubMed ID: 1484309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of daunomycin on myocardial contractility and on the action of beta-methyldigoxin.
    Bossa R; Galatulas I; Spiti R
    Pharmacology; 1980; 21(6):400-2. PubMed ID: 7220592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of the chronopharmacology of beta-methyldigoxin].
    Rengo F; Trimarco B; Saccà L; De Caprio L; Brevetti G; Giuffrida G; Condorelli M
    Boll Soc Ital Cardiol; 1975; 20(12):1821-6. PubMed ID: 1234480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of beta-methyldigoxin on the embryonal and fetal chicken heart].
    Rickenbacher J; Schläpfer R
    Schweiz Med Wochenschr; 1985 May; 115(18):625-9. PubMed ID: 4001908
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses.
    Rietbrock N; Guggenmos J; Kuhlmann J; Hess U
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):373-9. PubMed ID: 971702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of beta-methyldigoxin in healthy humans III: Pharmacodynamic correlations.
    Hinderling PH; Garrett ER
    J Pharm Sci; 1977 Mar; 66(3):326-9. PubMed ID: 851492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of beta-methyldigoxin (Lanitop)].
    Ostrowski K; Tracz P
    Pol Tyg Lek; 1974 Aug; 29(32):1395-7. PubMed ID: 4848295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.